Moreover, it is necessary to pay attention to the side effect profile of the combination of other CDK7 inhibitor and DMARD, which may include tolerable and limited gastrointestinal disturbance, skin rash, reversible transaminitis and hypokalaemia. This evidence concerns the gene CDK7 and Hypokalemia.